Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia
- PMID: 19913146
- DOI: 10.1016/j.contraception.2009.05.132
Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia
Abstract
Background: This study examined demographic profile, continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
Study design: A retrospective chart audit of 976 women who attended for implant insertion over a 3-year period between May 2001 and May 2004.
Results: Continuation rates showed that at 6 months after insertion, 94% of women continued, 74% continued at 1 year and 50% continued at 2 years. Metropolitan women were more likely than rural women to discontinue use because of dissatisfaction with bleeding patterns. Cox regression analysis showed that those attending the regional clinic experienced significantly shorter time to removal.
Conclusions: Implanon continuation rates and reasons for removal differ between clinics in metropolitan and rural locations. A cooling-off period did not affect the likelihood of continuation with Implanon. Preinsertion counselling should emphasize potential changes in bleeding patterns.
Similar articles
-
Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.Contraception. 2009 Nov;80(5):452-6. doi: 10.1016/j.contraception.2009.03.021. Epub 2009 May 14. Contraception. 2009. PMID: 19835719
-
Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.J Reprod Med. 1996 Nov;41(11):849-54. J Reprod Med. 1996. PMID: 8951137
-
The introduction of a new contraceptive; two years experience with Norplant.Health Bull (Edinb). 1996 Jul;54(4):314-7. Health Bull (Edinb). 1996. PMID: 8783485
-
The effects of Implanon on menstrual bleeding patterns.Eur J Contracept Reprod Health Care. 2008 Jun;13 Suppl 1:13-28. doi: 10.1080/13625180801959931. Eur J Contracept Reprod Health Care. 2008. PMID: 18330814 Review.
-
Tolerability and clinical safety of Implanon.Eur J Contracept Reprod Health Care. 2008 Jun;13 Suppl 1:29-36. doi: 10.1080/13625180801960012. Eur J Contracept Reprod Health Care. 2008. PMID: 18330815 Review.
Cited by
-
A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.Reprod Health. 2021 Jan 6;18(1):4. doi: 10.1186/s12978-020-01054-y. Reprod Health. 2021. PMID: 33407632 Free PMC article.
-
Beyond the Surface: Care Seeking Among Patients Initiating Contraceptive Implant in an Urban Federally Qualified Health Center Network.J Prim Care Community Health. 2017 Jan;8(1):20-25. doi: 10.1177/2150131916666011. Epub 2016 Sep 19. J Prim Care Community Health. 2017. PMID: 27587354 Free PMC article.
-
Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.BMC Res Notes. 2023 Mar 13;16(1):35. doi: 10.1186/s13104-023-06304-3. BMC Res Notes. 2023. PMID: 36915205 Free PMC article. Clinical Trial.
-
Acceptability and continuation of use of the subdermal contraceptive implant among adolescents and young women in Argentina: a retrospective cohort study.Sex Reprod Health Matters. 2023 Dec;31(1):2189507. doi: 10.1080/26410397.2023.2189507. Sex Reprod Health Matters. 2023. PMID: 37042700 Free PMC article.
-
An Interpretative Study of LARCs Discontinuation in Ethiopia: The Experiences of Women Accessing Contraceptives in Selected Public Health Facilities.Open Access J Contracept. 2023 Feb 17;14:41-51. doi: 10.2147/OAJC.S394590. eCollection 2023. Open Access J Contracept. 2023. PMID: 36824684 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources